Model Organisms in Drug Discovery

114 DROSOPHILA AS A TOOL FOR DRUG DISCOVERY
Lukacsovich, T., Asztalos, Z., Awano, U., Baba, K., Kondo, S., Niwa, S. and Yamamoto,
D. (2001). Dual-tagging gene trap of novel genes in Drosophila melanogaster. Genetics
157, 727–742.
MacKinnon, R., Cohen, S. L., Kuo, A., Lee, A. and Chait, B. T. (1998). Structural
conservation in prokaryotic and eukaryotic potassium channels. Science 280, 106–109.
Malicki, J., Schughart, K. and McGinnis, W. (1990). Mouse Hox-2.2 specifies thoracic
segmental identity in Drosophila embryos and larvae. Cell 63, 961–967.
Manseau, L., Baradaran, A., Brower, D., Budhu, A., Elefant, F., Phan, H., Phillip, A. V.,
et al. (1997). GAL4 enhancer traps expressed in the embryo, larval brain, imaginal discs
and ovary of Drosophila. Dev. Dynam. 209, 310–322.
Marin, I. and Baker, B. S. (1998). The evolutionary dynamics of sex determination. Science
281, 1990–1994.
Marsh, J. L., Walker, H., Theisen, H., Zhu, Y. Z., Fielder, T., Purcell, J. and Thompson,
L. M. (2000). Expanded polyglutamine peptides alone are intrinsically cytotoxic and
cause neurodegeneration in Drosophila. Hum. Mol. Genet. 9, 13–25.
Mata, J., Curado, S., Michon, A. M., Yoshida, S. and Ephrussi, A. (2000). Gain of
function screen in the female germ line. Dros. Res. Conf. Proc. 41, 372D.
Matthews, D. J. and Kopczynski, J. (2001). Using model-system genetics for drug-based
target discovery. Drug Discov. Today 6, 141–149.
McClung, C. and Hirsh, J. (1998). Stereotypic behavioral responses to free-base cocaine
and the development of behavioral sensitization in Drosophila. Curr. Biol. 8, 109–112.
McClung, C. and Hirsh, J. (1999). The trace amine tyramine is essential for sensitization to
cocaine in Drosophila. Curr. Biol. 9, 853–860.
McGinnis, N., Kuziora, M. A. and McGinnis, W. (1990). Human Hox-4.2 and Drosophila
deformed encode similar regulatory specificities in Drosophila embryos and larvae. Cell
63, 969–976.
Meyer, J. H., Goulding, V. S., Wilson, A. A., Hussey, D., Christensen, B. K. and Houle, S.
(2002). Bupropion occupancy of the dopamine transporter is low during clinical
treatment. Psychopharmacology (Berlin) 163, 102–105.
Mitchison, T. J. (1994). Towards a pharmacological genetics. Chem. Biol. 1, 3–6.
Moon, R. T., Bowerman, B., Boutros, M. and Perrimon, N. (2002). The promise and perils
of Wnt signaling through beta-catenin. Science 296, 1644–1646.
Moore, K. and Rees, S. (2001). Cell-based versus isolated target screening: how lucky do
you feel? J. Biomol. Screen 6, 69–74.
Morin, X., Daneman, R., Zavortink, M. and Chia, W. (2001). A protein trap strategy to
detect GFP-tagged proteins expressed from their endogenous loci in Drosophila. Proc.
Natl. Acad. Sci. USA 98, 15050–15055.
Nusse, R. (1999). WNT targets. Repression and activation. Trends Genet. 15, 1–3.
Nusslein-Volhard, C. and Wieschaus, E. (1980). Mutations affecting segment number and
polarity in Drosophila. Nature 287, 795–801.
Nuttall, M. E., Lee, J. C., Murdock, P. R., Badger, A. M., Wang, F. L., Laydon, J. T.,
Hofmann, G. A., et al. (1999). Amphibian melanophore technology as a functional
screen for antagonists of G-protein-coupled 7-transmembrane receptors. J. Biomol.
Screen. 4, 269–278.
Nystedt, S., Horn, C., Barmchi, M. P., Wimmer, E. A. and Hacker, U. (2002). Insertional
mutagenesis on FRT chromosomes using piggyBac based vectors. Dros. Res. Conf. Proc.
43, 985A.
OECD. (1984). Genetic Toxicology: Sex-linked Recessive Lethal Test in Drosophila
melanogaster. OECD Guideline For Testing of Chemicals. Paris: Organization for
Economic Cooperation and Development.